tiprankstipranks
Rhythm Biosciences Ltd. (AU:RHY)
ASX:RHY
Australian Market
RHY
Rhythm Biosciences Ltd.
RESEARCH TOOLSreports

Rhythm Biosciences Ltd. (RHY) Ratios

12 Followers

Rhythm Biosciences Ltd. Ratios

AU:RHY's free cash flow for Q2 2026 was AU$-46.24. For the 2026 fiscal year, AU:RHY's free cash flow was decreased by AU$ and operating cash flow was AU$-82.03. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
 2.31 0.84 1.58 4.03 8.33
Quick Ratio
 2.23 0.80 1.58 2.47 8.33
Cash Ratio
 1.74 0.65 1.26 2.34 8.10
Solvency Ratio
 -6.77 -1.67 -10.22 -4.41 -8.16
Operating Cash Flow Ratio
 -6.49 -1.35 -10.92 -3.94 -6.67
Short-Term Operating Cash Flow Coverage
 -23.30 -2.92 -78.33 -82.24 -72.66
Net Current Asset Value
AU$ 1.22MAU$ -360.29KAU$ 235.13KAU$ 5.30MAU$ 6.71M
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.39 0.11 0.01 0.02
Debt-to-Equity Ratio
 0.12 1.68 0.19 0.01 0.02
Debt-to-Capital Ratio
 0.11 0.63 0.16 0.01 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.45 4.29 1.75 1.31 1.14
Debt Service Coverage Ratio
 -18.79 -3.31 -81.66 -131.30 -78.66
Interest Coverage Ratio
 -102.17 -52.95 -2.13K 0.00 -349.17
Debt to Market Cap
 <0.01 0.07 <0.01 <0.01 <0.01
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 0.17 0.08 0.07 0.36 0.66
Profitability Margins
Gross Profit Margin
-6405.08%92.95%-80.30%93.86%-4.18%
EBIT Margin
-11459.72%-116.85%-505.55%-364.92%-461.72%
EBITDA Margin
-11174.50%-110.68%-493.79%-358.82%-457.52%
Operating Profit Margin
-11188.45%-110.68%-396.86%-372.80%-359.17%
Pretax Profit Margin
-11561.33%-119.97%-505.74%-265.44%-362.34%
Net Profit Margin
-9353.35%-119.97%-405.74%-265.44%-362.34%
Continuous Operations Profit Margin
-9353.35%-119.97%-405.74%-265.44%-362.34%
Net Income Per EBT
80.90%100.00%80.23%100.00%100.00%
EBT Per EBIT
103.33%108.39%127.43%71.20%100.88%
Return on Assets (ROA)
-215.43%-135.23%-451.50%-106.79%-104.22%
Return on Equity (ROE)
-476.27%-580.30%-790.74%-139.89%-119.29%
Return on Capital Employed (ROCE)
-370.23%-525.12%-700.93%-194.64%-116.14%
Return on Invested Capital (ROIC)
-267.03%-198.68%-483.21%-189.24%-82.40%
Return on Tangible Assets
-294.39%-193.15%-588.78%-112.49%-109.76%
Earnings Yield
-12.00%-26.34%-50.06%-9.24%-3.63%
Efficiency Ratios
Receivables Turnover
 1.16 51.56 45.43 47.26 29.45
Payables Turnover
 9.37 0.42 14.40 0.14 0.36
Inventory Turnover
 63.35 3.02 0.00 0.07 0.00
Fixed Asset Turnover
 0.78 18.66 6.08 16.61 10.08
Asset Turnover
 0.02 1.13 1.11 0.40 0.29
Working Capital Turnover Ratio
 0.16 -282.71 0.60 0.51 0.61
Cash Conversion Cycle
 280.76 -731.73 -17.31 2.77K -988.64
Days of Sales Outstanding
 313.97 7.08 8.03 7.72 12.39
Days of Inventory Outstanding
 5.76 120.68 0.00 5.33K 0.00
Days of Payables Outstanding
 38.97 859.49 25.34 2.57K 1.00K
Operating Cycle
 319.73 127.76 8.03 5.34K 12.39
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.02 -0.01 -0.03 -0.03 -0.03
Free Cash Flow Per Share
 -0.02 -0.01 -0.03 -0.03 -0.03
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.01 1.01 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
 -252.34 -125.86 -74.59 -70.19 -230.12
Capital Expenditure Coverage Ratio
 -252.34 -125.86 -74.59 -70.19 -230.12
Operating Cash Flow Coverage Ratio
 -23.30 -2.64 -37.46 -82.24 -36.53
Operating Cash Flow to Sales Ratio
 -85.66 -0.92 -3.63 -2.25 -2.56
Free Cash Flow Yield
-10.62%-20.25%-45.40%-7.94%-2.58%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -8.33 -3.80 -2.00 -10.82 -27.56
Price-to-Sales (P/S) Ratio
 809.56 4.56 8.11 28.72 99.84
Price-to-Book (P/B) Ratio
 25.96 22.03 15.80 15.14 32.87
Price-to-Free Cash Flow (P/FCF) Ratio
 -9.41 -4.94 -2.20 -12.60 -38.82
Price-to-Operating Cash Flow Ratio
 -9.10 -4.98 -2.23 -12.78 -38.99
Price-to-Earnings Growth (PEG) Ratio
 0.12 0.07 0.10 1.14 -1.86
Price-to-Fair Value
 25.96 22.03 15.80 15.14 32.87
Enterprise Value Multiple
 -7.07 -4.03 -1.58 -7.64 -21.16
Enterprise Value
 56.40M 14.25M 13.15M 84.89M 234.94M
EV to EBITDA
 -7.07 -4.03 -1.58 -7.64 -21.16
EV to Sales
 790.21 4.46 7.78 27.42 96.80
EV to Free Cash Flow
 -9.19 -4.84 -2.11 -12.03 -37.64
EV to Operating Cash Flow
 -9.22 -4.88 -2.14 -12.20 -37.80
Tangible Book Value Per Share
 <0.01 >-0.01 <0.01 0.02 0.03
Shareholders’ Equity Per Share
 <0.01 <0.01 <0.01 0.03 0.03
Tax and Other Ratios
Effective Tax Rate
 0.19 0.00 0.20 0.00 0.27
Revenue Per Share
 <0.01 0.01 <0.01 0.01 0.01
Net Income Per Share
 -0.02 -0.01 -0.03 -0.04 -0.04
Tax Burden
 0.81 1.00 0.80 1.00 1.00
Interest Burden
 1.01 1.03 1.00 0.73 0.78
Research & Development to Revenue
 22.82 0.43 1.39 1.18 2.13
SG&A to Revenue
 27.74 1.60 0.84 2.37 2.20
Stock-Based Compensation to Revenue
 4.90 0.11 0.00 0.97 1.07
Income Quality
 0.92 0.76 0.90 0.85 0.98
Currency in AUD